[HTML][HTML] Желудочковые нарушения ритма. Желудочковые тахикардии и внезапная сердечная смерть. Клинические рекомендации 2020

ДС Лебедев, ЕН Михайлов… - Российский …, 2021 - cyberleninka.ru
Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …

Cardiac stereotactic ablative radiotherapy for refractory ventricular arrhythmias: A radical alternative? A narrative review of rationale and cardiological aspects

K Benali, J Bellec, N Jaksic, P Caille, L Rigal… - Journal of Medical …, 2021 - Elsevier
Ventricular arrhythmias are serious life-threatening cardiac disorders. Despite many
technological improvements, a non-negligible number of patients present refractory …

[PDF][PDF] Accounting Management for Decision Making

CIC Villalba, MJH Sánchez, L Soto-Soto… - Journal of Positive …, 2021 - sga.unemi.edu.ec
A documentary review was carried out on the production and publication of research papers
related to the study of Accounting Management for Decision Making. The purpose of the …

[HTML][HTML] Machine learning-based phenomapping in patients with heart failure and secondary prevention implantable cardioverter-defibrillator implantation: a proof-of …

Y Deng, S Cheng, H Huang, X Liu, Y Yu… - Reviews in …, 2023 - imrpress.com
Background: Previous studies have failed to implement risk stratification in patients with
heart failure (HF) who are eligible for secondary implantable cardioverter-defibrillator (ICD) …

[HTML][HTML] Myocardial scar characterization and future ventricular arrhythmia in patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator

ABP Noordman, AH Maass, H Groenveld… - Frontiers in …, 2021 - frontiersin.org
Background: Implantable cardioverter-defibrillator (ICD) therapy is associated with several
deleterious effects, which can be reduced by antiarrhythmic drugs or catheter ablation …

[HTML][HTML] Utility of ischemia testing prior to ablation for sustained monomorphic ventricular tachycardia

NK Mehta, C Schumann, G Davogustto… - The Journal of …, 2022 - ncbi.nlm.nih.gov
The aim of this study was to determine the relationship between ischemia testing prior to
ablation for sustained monomorphic ventricular tachycardia (VT)(SMVT) and post-ablation …

Pharmacological therapy for ventricular arrhythmias: a state-of-the art review

KKM Chia, L Kanagaratnam, K Hellestrand… - Heart, Lung and …, 2019 - Elsevier
While implantable cardioverter defibrillators decrease mortality in high risk groups of
patients who have ventricular arrhythmias, antiarrhythmic drugs are still required to reduce …

Comparable risk of recurrent ventricular tachyarrhythmias in implantable cardioverter‐defibrillator recipients treated with single beta‐blocker or combined amiodarone

T Schupp, M Behnes, S Kim, J Müller… - Basic & Clinical …, 2021 - Wiley Online Library
This study sought to assess the prognostic impact of treatment with single beta‐blocker (BB)
compared to combined therapy with BB plus amiodarone (BB‐AMIO) on recurrences of …

[HTML][HTML] Risk of subsequent ventricular arrhythmia is higher in primary prevention patients with implantable cardioverter defibrillator than in secondary prevention …

Y Zhou, S Zhao, K Chen, W Hua, Y Su, S Chen… - BMC Cardiovascular …, 2019 - Springer
Background Because of previous ventricular arrhythmia (VA) episodes, patients with
implantable cardioverter-defibrillator (ICD) for secondary prevention (SP) are generally …

A successful catheter ablation of a ventricular fibrillation

S Demir, A Uslu, A Guner, S Gunduz… - Journal of …, 2018 - Elsevier
Malignant ventricular arrhythmias are challenging to manage, requiring a multidisciplinary
approach. The mechanism, which triggers ventricular fibrillation (VF) associated with …